Oligodendroglioma: all 225 studies
Page 3 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.
- Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
- Sorafenib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00093613Phase 1
- A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant GliomasCompletedNCT00080054Phase 1
- Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaCompletedNCT00070525Phase 2
- Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant GliomaCompletedNCT00064779Phase 1
- Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
- Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTerminatedNCT00062504Phase 2
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
- Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research ProtocolsTerminatedNCT00035373
- Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic OligoastrocytomasCompletedNCT00033280Phase 2
- Genetic Analysis of Brain TumorsTerminatedNCT00031538
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
- Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaCompletedNCT00010049Phase 1/2
- Natural History of Patients With Brain and Spinal Cord TumorsCompletedNCT00009035
- Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaCompletedNCT00008008Phase 2
- Bortezomib in Treating Patients With Recurrent GliomaTerminatedNCT00006773Phase 1
- Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedNCT00004688Phase 2
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or OligodendrogliomaCompletedNCT00004024Phase 2
- Temozolomide in Treating Patients With Anaplastic OligodendrogliomaCompletedNCT00003465Phase 2
- Topotecan in Treating Patients With Recurrent Brain TumorsCompletedNCT00003372Phase 2
- Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With OligodendrogliomaCompletedNCT00003101Phase 2
- Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic OligodendrogliomaCompletedNCT00002840Phase 3
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic OligodendrogliomaCompletedNCT00002569Phase 3